SPATA13-AS1: A Drug Target / Disease Biomarker (G100874231)

Target Name: SPATA13-AS1

NCBI ID: G100874231

SPATA13-AS1

Other Name(s): SPATA13 antisense RNA 1

SPATA13-AS1: A Drug Target / Disease Biomarker

SPATA13-AS1 is a protein that is expressed in the brain and is involved in the regulation of spinal cord growth and development. It has been shown to play a role in the development and progression of various neurological disorders, including spinal muscular atrophy and neurodegenerative diseases. As a result, SPATA13-AS1 has potential as a drug target or biomarker for a variety of neurological conditions.

SPATA13-AS1 is a member of the SPATA gene family, which is known for its role in the development and maintenance of spinal cord development and integrity. The SPATA gene family has been shown to be involved in the regulation of various cellular processes that are critical for spinal cord development, including cell survival, proliferation, and differentiation.

SPATA13-AS1 is expressed in the brain and is involved in the regulation of spinal cord growth and development.

One of the key functions of SPATA13-AS1 is its role in the regulation of the size and structure of the spinal cord. The spinal cord is a vital structure that carries nerve signals from the brain to the rest of the body. It is made up of a variety of different cell types, including motor neurons and nerve fibers, and its proper development and function are essential for the development of normal movement and sensation.

SPATA13-AS1 is involved in the regulation of the size and structure of the spinal cord through its ability to control the activity of genes that are responsible for the production of the cytoskeleton. The cytoskeleton is the protein framework that gives structure to the cell and is involved in many different cellular processes, including cell division, migration, and storage.

SPATA13-AS1 has been shown to play a role in the regulation of the cytoskeleton by controlling the activity of genes that are involved in its production. This is important because the cytoskeleton plays a critical role in the structure and function of the spinal cord, and alterations in its structure or function can contribute to the development and progression of various neurological disorders.

SPATA13-AS1 is also involved in the regulation of the expression of other genes that are involved in the development and function of the spinal cord. This is important because the expression of these genes can be regulated by a variety of different factors, including SPATA13-AS1 itself.

SPATA13-AS1 has been shown to play a role in the regulation of the expression of genes that are involved in the development and function of the spinal cord.

In addition to its role in regulating the size and structure of the spinal cord, SPATA13-AS1 is also involved in the regulation of the development and progression of various neurological disorders. For example, SPATA13-AS1 has been shown to play a role in the development and progression of spinal muscular atrophy, a genetic disorder that is characterized by the progressive loss of motor neurons.

SPATA13-AS1 has been shown to play a role in the development and progression of spinal muscular atrophy by regulating the expression of genes that are involved in its development. This is important because the loss of motor neurons in spinal muscular atrophy can have a significant impact on an individual's ability to move and function.

SPATA13-AS1 is also involved in the regulation of the expression of genes that are involved in the development and progression of neurodegenerative diseases. Neurodegenerative diseases are a group of conditions that are characterized by the progressive loss of normal brain cells and the development of characteristic symptoms and disabilities.

SPATA13-AS1 has been shown to play a role in the regulation of the expression of genes that are involved in the development and progression of neurodegenerative diseases by regulating the activity of genes that are involved in its production. This is important because the loss of normal brain cells in neurodegenerative diseases can have a significant impact on an individual's ability to function and maintain their independence.

In conclusion, SPATA13-AS1 is a protein that is involved in the regulation of spinal cord growth and development. It has been shown to play a role in the development and progression of various neurological disorders, including spinal muscular atrophy and neurodegenerative diseases. As a result, SPATA13-AS1 has potential as a drug target or biomarker for a variety of neurological conditions. Further research is needed to fully understand the role of SPATA13-AS1 in the development and progression of these conditions and to develop effective treatments.

Protein Name: SPATA13 Antisense RNA 1

The "SPATA13-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SPATA13-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets